Oklahoma Attorney General targets pharmacy benefits managers violations with new enforcement rules

Oklahoma's Senate Bill 773 is making waves as it seeks to empower the Attorney General to take decisive action against pharmacy benefits managers (PBMs) that violate patient rights and pharmacy integrity laws. Introduced on February 24, 2025, the bill aims to enhance accountability within the pharmaceutical industry by allowing the Attorney General to censure, suspend, or revoke the licenses of PBMs found in violation of the Patient’s Right to Pharmacy Choice Act and the Pharmacy Audit Integrity Act.

Key provisions of SB773 include the authority for the Attorney General to impose civil fines ranging from $100 to $10,000 for each violation, alongside the potential for restitution to pharmacies and patients affected by these infractions. This legislative move is a direct response to growing concerns over PBM practices that may undermine patient access to medications and fair pharmacy operations.

The bill has sparked notable debates among lawmakers and stakeholders. Proponents argue that it is a necessary step to protect patients and ensure fair competition in the pharmacy sector, while opponents raise concerns about the potential for overreach and the impact on PBM operations. The discussions highlight a broader tension in healthcare policy, balancing regulation with market freedom.

The implications of SB773 could be significant, potentially reshaping the landscape of pharmacy benefits management in Oklahoma. Experts suggest that if passed, the bill could lead to increased scrutiny of PBM practices, fostering a more transparent and equitable environment for both pharmacies and patients. As the bill progresses through the legislative process, its fate remains uncertain, but its introduction signals a growing commitment to safeguarding patient rights in the state.